233 related articles for article (PubMed ID: 30745384)
1. Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of
Buckner FS; Ranade RM; Gillespie JR; Shibata S; Hulverson MA; Zhang Z; Huang W; Choi R; Verlinde CLMJ; Hol WGJ; Ochida A; Akao Y; Choy RKM; Van Voorhis WC; Arnold SLM; Jumani RS; Huston CD; Fan E
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745384
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
3. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
[TBL] [Abstract][Full Text] [Related]
4. Emerging treatment options for cryptosporidiosis.
Love MS; Choy RKM
Curr Opin Infect Dis; 2021 Oct; 34(5):455-462. PubMed ID: 34261904
[TBL] [Abstract][Full Text] [Related]
5. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
[No Abstract] [Full Text] [Related]
6. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
7. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
Manjunatha UH; Chao AT; Leong FJ; Diagana TT
ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of methionyl-tRNA synthetase have potent activity against Giardia intestinalis trophozoites.
Ranade RM; Zhang Z; Gillespie JR; Shibata S; Verlinde CL; Hol WG; Fan E; Buckner FS
Antimicrob Agents Chemother; 2015 Nov; 59(11):7128-31. PubMed ID: 26324270
[TBL] [Abstract][Full Text] [Related]
9. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
11. The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases.
Guo F; Zhang H; McNair NN; Mead JR; Zhu G
J Infect Dis; 2018 Mar; 217(7):1110-1117. PubMed ID: 29300993
[TBL] [Abstract][Full Text] [Related]
12. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
13. Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase.
Palencia A; Liu RJ; Lukarska M; Gut J; Bougdour A; Touquet B; Wang ED; Li X; Alley MR; Freund YR; Rosenthal PJ; Hakimi MA; Cusack S
Antimicrob Agents Chemother; 2016 Oct; 60(10):5817-27. PubMed ID: 27431220
[TBL] [Abstract][Full Text] [Related]
14. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
Funkhouser-Jones LJ; Ravindran S; Sibley LD
mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
[No Abstract] [Full Text] [Related]
15. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
16. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
17. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Selection of
Hasan MM; Stebbins EE; Choy RKM; Gillespie JR; de Hostos EL; Miller P; Mushtaq A; Ranade RM; Teixeira JE; Verlinde CLMJ; Sateriale A; Zhang Z; Osbourn DM; Griggs DW; Fan E; Buckner FS; Huston CD
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753338
[TBL] [Abstract][Full Text] [Related]
19. Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening.
Chattopadhyay S; Mahapatra RK
Parasitol Res; 2019 Nov; 118(11):3159-3171. PubMed ID: 31486948
[TBL] [Abstract][Full Text] [Related]
20. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
